Vancouver, B.C. / TheNewswire / May 4, 2017 – MYM Nutraceuticals Inc. (CSE:MYM) (OTC:MYMMF) (the “Company” or “MYM”), is pleased to announce a non-brokered private placement of up to 8,333,333 units at a price of $0.18 per unit.  

Each unit will consist of one common share and one non-transferable share purchase warrant. Each whole warrant will entitle the holder to acquire one additional common share exercisable for a period of twelve months following the closing of the private placement at a price of $0.40 per warrant share subject to certain acceleration terms.  

All or a portion of this placement could be subject to finder’s fees or commissions.

The private placement is subject to the approval of the Canadian Securities Exchange and the securities will be subject to a four month and one day hold period under securities laws.  

 

The Company intends to use the net proceeds from the private placement for general working capital and corporate purposes.

 

About MYM

MYM Nutraceuticals Inc. is a public company whose primary focus is developing high-end organic medicinal supplements and topical products. MYM has an interest in the development of high-density farming facilities and other technologies that allow MYM to expand its brand into the global market.

 

MYM shares trade in Canada and Germany under the following symbols: (CSE:MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY)

 

ON BEHALF OF THE BOARD

“Jonathan Fiteni”

Jonathan Fiteni, Director
MYM Nutraceuticals Inc.
www.mymarijuana.ca

    

This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties, which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.

This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), accepts responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law and may not be offered or sold in the “United States”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.